Medication comparison
Mounjaro vs Wegovy HD
Medically reviewed by Dr. Jane Novak, MD, MPH 8 min read Fact checked Editorial integrityUpdated Jun 5, 2026
Mounjaro and Wegovy HD are both prescription medications (GIP/GLP-1 dual receptor agonist vs GLP-1 receptor agonist) used for Type 2 diabetes and Chronic weight management (BMI >=30, or >=27 with at least one weight-related comorbidity). The table below compares FDA-approved indications, dosing, weight-loss outcomes, side effects, contraindications, and current pricing — all sourced from the manufacturer prescribing information.